Comparison between Aprameya Engineering IPO and Clinitech Laboratory IPO.
Aprameya Engineering IPO is a SME Fixed Price IPO proposed to list at NSE SME while Clinitech Laboratory IPO is a SME Fixed Price proposed to list at BSE SME.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Hem Securities Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Hem Finlease Pvt.Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aprameya Engineering IPO is up to ₹27.76 Cr whereas the issue size of the Clinitech Laboratory IPO is up to ₹5.48 Cr. The final issue price of Aprameya Engineering IPO is ₹58.00 per share and of Clinitech Laboratory IPO is ₹96.00 per share.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹56.00 per share | |
| Issue Price (Upper) | ₹58.00 per share | |
| Issue Price (Final) | ₹58.00 per share | ₹96.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 47,86,000 shares | 5,71,200 shares |
| Fresh Issue Size (Amount) | up to ₹27.76 Cr | up to ₹5.48 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 47,86,000 shares | 5,71,200 shares |
| Issue Size Total (Amount) | up to ₹27.76 Cr | up to ₹5.48 Cr |
Aprameya Engineering IPO opens on Jul 25, 2024, while Clinitech Laboratory IPO opens on Jul 25, 2024. The closing date of Aprameya Engineering IPO and Clinitech Laboratory IPO is Jul 29, 2024, and Jul 29, 2024, respectively.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |
|---|---|---|
| Anchor Bid Date | Jul 24, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 25, 2024 |
| Issue Close | Jul 29, 2024 | Jul 29, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 30, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 31, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 31, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Aug 01, 2024 |
| Anchor Lockin End date 1 | Aug 29, 2024 | |
| Anchor Lockin End date 2 | Oct 28, 2024 |
Aprameya Engineering IPO P/E ratio is 23.49, as compared to Clinitech Laboratory IPO P/E ratio of 43.45.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Aprameya Engineering Limited Financial Information (Restated)Aprameya Engineering Limited's revenue decreased by -16.23% and profit after tax (PAT) dropped by -35.62% between the financial year ending with March 31, 2024 and March 31, 2023.
| Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 83.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 61.56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.49 | 43.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹110.43 Cr. | ₹21.91 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15.97% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 9.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.80 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.47 | ₹2.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.79% | 10.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aprameya Engineering IPO Retail Individual Investors (RII) are offered 16,76,000 shares while in Clinitech Laboratory IPO retail investors are offered 16,76,000 shares. Qualified Institutional Buyers (QIB) are offered 9,58,000 shares in Aprameya Engineering IPO and in Clinitech Laboratory IPO.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |
|---|---|---|
| Anchor Investor Reserveration | 14,34,000 shares | |
| Market Maker Reserveration | 2,54,000 shares | 31,200 shares |
| QIB | 9,58,000 shares | |
| NII | 7,18,000 shares | 2,85,600 shares |
| RII | 16,76,000 shares | 2,85,600 shares |
| Employee | ||
| Others | ||
| Total | 47,86,000 shares | 5,71,200 shares |
Aprameya Engineering IPO subscribed 192.57x in total, whereas Clinitech Laboratory IPO subscribed 38.96x.
| Aprameya Engineering IPO | Clinitech Laboratory IPO | |
|---|---|---|
| QIB (times) | 90.29x | |
| NII (times) | 339.99x | 23.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 187.88x | 49.61x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 192.57x | 38.96x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
